Acute sympathoinhibitory actions of metformin in spontaneously hypertensive rats

Hypertension

Volumn 27, Issue 3 II, 1996, Pages 619-625

  Petersen, Jørgen S ^a   DiBona, Gerald F ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

baroreflex; blood pressure; central nervous system; indomethacin; L NAME; metformin; vagotomy

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; INDOMETACIN; INSULIN; METFORMIN; N(G) NITROARGININE METHYL ESTER;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; HYPERTENSION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SPONTANEOUSLY HYPERTENSIVE RAT; VAGOTOMY;

EID: 0029919722     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.27.3.619     Document Type: Conference Paper

References (34)

1. United Kingdom Prospective Diabetes Study Group. United Kingdom prospective diabetes study (UKPDS) 13: relative efficacy of randomly allowed diet, sulfonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. Br Med J. 1995;310:83-88.
2. Montaguti U, Celin D, Ceredi C, Descovich GC. Efficacy of the long-term administration of metformin in hyperlipidaemic patients. Res Clin Forums. 1979;1:95-103.
3. Campbell IW, Duncan C, Patton NW, Broadhead T, Tucker GT, Woods HF. The effect of metformin on glycemic control, intermediary metabolism and blood pressure in non-insulin-dependent diabetes mellitus. Diabet Med. 1987;4:337-341.
4. Vague P, Juhan-Vague I, Alessi MC, Badier C, Valadier J. Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects. Thromb Haemost. 1987;57:326-328.
5. De Fronzo RA, Barzilai N, Simonson DC. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects. J Clin Endocrinol Metab. 1991;73:1294-1301.
6. Haupt E, Knick B, Koschinsky T, Liebermeister H, Schneider J, Hirche H. Oral antidiabetic combination therapy with sulphonylureas and metformin. Diabete Metab. 1991;17:224-231.
7. Chan JCN, Tomlinson B, Critchley JAJH, Cockram CS, Walden RJ. Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients. Diabetes Care. 1993;16: 1035-1038.
8. Giugliano D, De Rosa N, Di Maro G, Marfella R, Acampora R, Buininconti R, D'Onofrio F. Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women. Diabetes Care. 1993;16:1387-1390.
9. Giugliano D, Quatraro A, Consoli G, Minei A, Ceriello A, De Rosa N, D'Onofrio F. Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors. Eur J Clin Pharmacol. 1993;44:107-112.
10. Landin K, Tengborn L, Smith U. Metformin and metoprolol CR treatment in non-obese men. J Intern Med. 1994;235:335-341.
11. DeFronzo RA, Goodman AM, and the Multicenter Metformin Study Group. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 1995;333:541-549.
12. Landin K, Tengborn L, Smith U. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. J Intern Med. 1991;229:181-187.
13. Morgan DA, Ray CA, Ballon TW, Mark AL. Metformin increases insulin sensitivity and lowers arterial pressure in spontaneously hypertensive rats. Hypertension. 1992;20:421. Abstract.
14. Verma S, Bhanot S, McNeil JH. Metformin decreases plasma insulin levels and systolic blood pressure in spontaneously hypertensive rats. Am J Physiol. 1994;267:H1250-H1253.
15. Verma S, Bhanot S, McNeil JH. Antihypertensive effects of metformin in fructose-fed hyperinsulinemic, hypertensive rats. J Pharmacol Exp Ther. 1994;271:1334-1337.
16. Anderson EA, Mark AL. The vasodilator action of insulin: implications for the insulin hypothesis in hypertension. Hypertension. 1993;21:136-141.
17. Morgan DA, Ballon TW, Ginsberg B, Mark AL. Nonuniform regional sympathetic nerve responses to hyperinsulinemia in rats. Am J Physiol. 1993;264:R423-R427.
18. Muntzel M, Beltz T, Mark AL, Johnson AK. Anteroventral third ventricle lesions abolish lumbar sympathetic responses to insulin. Hypertension. 1994;23:1059-1062.
19. Veelken R, Sawin LL, DiBona GF. Epicardial serotonin receptors in circulatory control in conscious Sprague-Dawley rats. Am J Physiol. 1990;258:H466-H472.
20. Petersen JS, DiBona GF. Furosemide elicits non-uniform reflex responses via cardiac sympathetic afferents. Hypertension. 1994;23: 924-930.
21. Togashi H, Sakuma I, Yoshioka M, Kobayashi T, Yasuda H, Kitabatake A, Saito H, Gross SS, Levi R. A central nervous system action of nitric oxide in blood pressure regulation. J Pharmacol Exp Ther. 1992;262:343-347.
22. Zanzinger J, Czachurski J, Seller H. Inhibition of sympathetic vasoconstriction is a major principle of vasodilation by nitric oxide in vivo. Circ Res. 1994;75:1073-1077.
23. Zanzinger J, Czachurski J, Seller H. Inhibition of basal and reflex-mediated sympathetic activity in the RVLM by nitric oxide. Am J Physiol. 1995;268:R958-R962.
24. Krieger EM. Neurogenic hypertension in the rat. Circ Res. 1964;15: 511-521.
25. Petersen JS, Hinojosa-Laborde C, DiBona GF. Sympathoinhibitory responses to 2-methyl-serotonin during changes in sodium intake. Hypertension. 1993;21:1000-1004.
26. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res. 1980;47:1-9.
27. Hermann LS, Scherstén B, Bitzén P-O, Kjellström T, Lindgärde F, Melander A. Therapeutic comparison of metformin and sulphonylurea, alone and in various combinations: a double-blind controlled study. Diabetes Care. 1994;17:1100-1109.
28. Semplicini A, Del Prato S, Giusto M, Campagnolo M, Palatini P, Rossi GP, Valle R, Dorella M, Albertini G, Pessina AC. Short-term effects of metformin on insulin sensitivity and sodium homeostasis in essential hypertensives. J Hypertens. 1993;11(suppl 5):S276-S277.
29. Gudbjörnsdottir S, Friberg P, Elam M, Attvall S, Lönnroth P, Wallin BG. The effect of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men. Blood Pressure. 1994;3:394-403.
30. Tuck ML. Obesity, the sympathetic nervous system, and essential hypertension. Hypertension. 1992;19(suppl I):I-68-I-77.
31. Zhang HY, Reddy SR, Kotchen TA. Antihypertensive effect of pioglitazone is not invariably associated with increased insulin sensitivity. Hypertension. 1994;25:106-110.
32. Katayama S, Abe M, Kashiwabara H, Kosegawa I, Ishii J. Evidence against a role of insulin in hypertension in spontaneously hypertensive rats: CS-045 does not lower blood pressure despite improvement of insulin resistance. Hypertension. 1994;23:1071-1974.
33. Morgan DA, Mark AL. Contrasting effects of metformin and ciglitazone on sympathetic nerve responses to insulin. FASEB J. 1993; 7:A653. Abstract.
34. Lembo G, Iaccarino G, Vecchione C, Rendina V, Trimarco B. Insulin modulation of vascular reactivity is already impaired in prehypertensive spontaneously hypertensive rats. Hypertension. 1995;26:290-293.